Evidence map›Paper›PMID 30249139›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2018

Novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group acting as human carbonic anhydrase IX inhibitors.

Özlen Güzel-Akdemir, Andrea Angeli, Kübra Demir, Claudiu T Supuran, Atilla Akdemir

Abstract read
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Development of Thiazolidinones as Fungal Carbonic Anhydrase Inhibitors.International journal of molecular sciences · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Cloning, Purification, and Characterization of a β-Carbonic Anhydrase fromInternational journal of molecular sciences · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Özlen Güzel-Akdemira Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Istanbul University , Istanbul , Turkey.
Andrea Angelib Department of NEUROFARBA , Sezione di Scienze Farmaceutiche Universita degli Studi di Firenze , Sesto Fiorentino , Florence , Italy.
Kübra Demira Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Istanbul University , Istanbul , Turkey.
Claudiu T Supuranb Department of NEUROFARBA , Sezione di Scienze Farmaceutiche Universita degli Studi di Firenze , Sesto Fiorentino , Florence , Italy.ORCID https://orcid.org/0000-0003-4262-0323
Atilla Akdemirc Computer-Aided Drug Discovery Laboratory, Department of Pharmacology, Faculty of Pharmacy , Bezmialem Vakif University , Istanbul , Turkey.ORCID https://orcid.org/0000-0001-8416-0471

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A small collection of 26 structurally novel thiazolidinone-containing compounds, without the well-known sulphonamide zinc-binding group, were synthesised and tested in enzyme inhibition assays against the tumour-associated hCA IX enzyme. Inhibition constants in the lower micromolar region (K

Indexed as

Antigens, NeoplasmCarbonic Anhydrase InhibitorsCarbonic Anhydrase IXDose-Response Relationship, DrugHumansMolecular Dynamics SimulationMolecular StructureOrganometallic CompoundsStructure-Activity RelationshipSulfanilamideSulfanilamidesThiazolidinesZincAntigens, NeoplasmCA9 protein, humanCarbonic Anhydrase InhibitorsCarbonic Anhydrase IXOrganometallic CompoundsSulfanilamideSulfanilamidesThiazolidinesZinccarbonic anhydrase IXdockinghCA IXmolecular modellingthiazolidinone

Identifiers

PMID30249139
PMCPMC6161604

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.